Clinical Trial Update: Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update evaluating safety and efficacy of β-globin–restored autologous hematopoietic stem cells in β-thalassemia major, sponsored by S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Beta-thalassemia

Drugs mentioned

• β-globin Restored Autologous Hematopoietic Stem Cells

Snippet

Sponsor: Shenzhen Hemogen | Conditions: β-thalassemia | EARLY_Phase 1 | Status: RECRUITING